85. On the Shoulders of Giants
Friday, October 21, 2011: 2:15 PM-4:15 PM
Room: 205ABC

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • review the historical and contemporary risk factors for infections in patients with cancer and transplantation
  • discuss the rationale for combination antibacterial therapy for emerging Gram-negative bacteria
  • identify basic principle of epidemiology, host defenses, and treatment of invasive fungal infections in patients with cancer
  • characterize the emerging pathogens and evolving hosts in solid organ transplant recipients

Target Audience: Pharmacists, Epidemiologists, Clinicians, Academicians

Tracks: Adult ID

Moderators:  Thomas Walsh, MD, FIDSA, Weill Cornell Medical College of Cornell University and Dimitrios Kontoyiannis, MD, ScD, FACP, FIDSA, MD Anderson Cancer Center, Houston, TX

CME Credits: Maximum of 2.0 hours of Category 1 credit possible

ACPE Credits: ACPE 2.0 knowledge-based contact hours (0.2 CEU) of Pharmacy CE

ACPE Number: 0461-9999-11-166-L01-P


T. Walsh, Vestagen: Consultant, Consulting fee
Novartis: Collaborator and Investigator, Grant recipient
Astellas: Collaborator, Consultant and Investigator, Grant recipient
iCo: Board Member, Consulting fee
Trius: Consultant, Consulting fee
Sigma Tau: Consultant, Consulting fee
Drais: Consultant, Consulting fee

D. Kontoyiannis, None

G. Bodey, None

J. Klastersky, None

D. Armstrong, None

R. H. Rubin, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.